|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS12171 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-SET |
| 克隆性 | 是 |
| 靶點(diǎn) | 詳見(jiàn)說(shuō)明書(shū) |
| 適應(yīng)物種 | 詳見(jiàn)說(shuō)明書(shū) |
| 形態(tài) | 詳見(jiàn)說(shuō)明書(shū) |
| 宿主 | 詳見(jiàn)說(shuō)明書(shū) |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書(shū) |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human SET translocation. |
技術(shù)外包服務(wù):
★SET易位蛋白/髓系相關(guān)蛋白抗體品牌 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
實(shí)驗(yàn)流程：
SET易位蛋白/髓系相關(guān)蛋白抗體品牌 英文名稱 Anti-SET
中文名稱 SET易位蛋白/髓系相關(guān)蛋白抗體品牌
別 名 2PP2A; HLA DR associated protein II; HLA-DR-associated protein II; I 2PP2A; I-2PP2A; I2PP2A; IGAAD; Inhibitor of granzyme A activated DNase; Inhibitor of granzyme A-activated DNase; PHAPII; Phosphatase 2A inhibitor I2PP2A; Protein SET; Set; SET translocation; SET translocation (myeloid leukemia-associated); SET_HUMAN; TAF I; TAF IBETA; TAF-I; TAFI; Template activating factor I; Template-activating factor I.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類(lèi)型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Rabbit
產(chǎn)品類(lèi)型 一抗
研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 染色質(zhì)和核信號(hào) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 細(xì)胞周期蛋白 t-淋巴細(xì)胞
蛋白分子量 predicted molecular weight: 32kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human SET translocation.
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
SET易位蛋白/髓系相關(guān)蛋白抗體品牌 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-induced apoptosis, GZMA cleaves SET, disrupting its binding to NME1 and releasing NME1 inhibition. Isoform 1 and isoform 2 are potent inhibitors of protein phosphatase 2A. Isoform 1 and isoform 2 inhibit EP300/CREBBP and PCAF-mediated acetylation of histones (HAT) and nucleosomes, most probably by masking the accessibility of lysines of histones to the acetylases. The predominant target for inhibition is histone H4. HAT inhibition leads to silencing of HAT-dependent transcription and prevents active demethylation of DNA. Both isoforms stimulate DNA replication of the adenovirus genome complexed with viral core proteins; however, isoform 2 specific activity is higher.
Function : ultitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-induced apoptosis, GZMA cleaves SET, disrupting its binding to NME1 and releasing NME1 inhibition. Isoform 1 and isoform 2 are potent inhibitors of protein phosphatase 2A. Isoform 1 and isoform 2 inhibit EP300/CREBBP and PCAF-mediated acetylation of histones (HAT) and nucleosomes, most probably by masking the accessibility of lysines of histones to the acetylases. The predominant target for inhibition is histone H4. HAT inhibition leads to silencing of HAT-dependent transcription and prevents active demethylation of DNA. Both isoforms stimulate DNA replication of the adenovirus genome complexed with viral core proteins; however, isoform 2 specific activity is higher.
Subunit : Isoform 1 and isoform 2 interact directly with each other and with ANP32A within the tripartite INHAT (inhibitor of acetyltransferases) complex. Isoform 1 and isoform 2 interact also with histones. Isoform 2 is a component of the SET complex, which also contains ANP32A, APEX1, HMGB2 and NME1, but not NME2. Within this complex, directly interacts with NME1 and with HMGB2. Interacts with SETBP1. Interacts with SGOL1. Interacts with APBB1.
Subcellular Location : Cytoplasm > cytosol. Endoplasmic reticulum. Nucleus > nucleoplasm. In the cytoplasm, found both in the cytosol and associated with the endoplasmic reticulum. Following CTL attack, moves rapidly to the nucleus, where it is found in the nucleoplasm, avoiding the nucleolus. Similar translocation to the nucleus is also observed for lymphocyte-activated killer cells after the addition of calcium. The SET complex is associated with the endoplasmic reticulum.
Tissue Specificity : Widely expressed. Low levels in quiescent cells during serum starvation, contact inhibition or differentiation. Highly expressed in Wilms' tumor
Post-translational modifications : Isoform 2 is phosphorylated on Ser-15 and Thr-23.
Isoform 2 is acetylated on Lys-11.
Some glutamate residues are glycylated by TTLL8. This modification occurs exclusively on glutamate residues and results in a glycine chain on the gamma-carboxyl group.
N-terminus of isoform 1 is methylated by METTL11A/NTM1. Mainly trimethylated.
DISEASE : Note=A chromosomal aberration involving SET is found in some cases of acute undifferentiated leukemia (AUL). Translocation t(6;9)(q21;q34.1) with NUP214/CAN.
Similarity : Belongs to the nucleosome assembly protein (NAP) family.
Database links : UniProtKB/Swiss-Prot: Q01105.3
全、新、優(yōu)、品、好四大特點(diǎn)：
SET易位蛋白/髓系相關(guān)蛋白抗體品牌 全：公司提供上萬(wàn)種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。
正在熱銷(xiāo)的相關(guān)產(chǎn)品：
SH2域含蛋白1A 多克隆抗體 SH21A Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
SH2域含蛋白3A 多克隆抗體 SH23A Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
SH2B銜接蛋白3 多克隆抗體 SH2B3 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
SH2域含蛋白3C 多克隆抗體 SH2D3 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
SH3結(jié)構(gòu)域結(jié)合蛋白4 多克隆抗體 SH3B4 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
腺苷單磷酸活化蛋白激酶β2抗體 轉(zhuǎn)錄調(diào)節(jié)因子DACH2抗體
細(xì)胞周期末期促進(jìn)復(fù)合蛋白APC1抗體 轉(zhuǎn)錄調(diào)節(jié)因子C/EBPγ抗體
磷酸化蛋白激酶B2抗體 轉(zhuǎn)錄調(diào)節(jié)因子C/EBP β抗體
磷酸化鐵蛋白Fe65抗體 轉(zhuǎn)錄調(diào)節(jié)因子C/EBP α 抗體
發(fā)育分化增強(qiáng)因子1抗體 轉(zhuǎn)錄調(diào)節(jié)蛋白BACH2抗體
轉(zhuǎn)錄輔助因子退變樣蛋白4 多克隆抗體 VGLL4 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
溶質(zhì)載體家族17(依賴無(wú)機(jī)磷酸協(xié)同轉(zhuǎn)運(yùn)蛋白)成員6 多克隆抗體 VGLU2 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
vonHippel-Lindau抑制因子 多克隆抗體 VHL Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
極受體 多克隆抗體 VLDLR Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
波形蛋白IF關(guān)聯(lián)卷曲螺旋蛋白 多克隆抗體 VMAC Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
毛茛科植物打破碗花 Anemone hupehensis Presapogenin CP4 75799-18-7 C46H74O15 ≥98%
鴨腳樹(shù)葉減PicrininqHPLC≥98%，20mg/支
錄化矮牽牛素 Petunidin Chloride 1429-30-7 20mg HPLC≥98% 錄化矮牽牛素 1429-30-7
含量測(cè)定鹽酸格拉司瓊100558-200602常溫，避光50mg
Demecarium Bromide地美溴銨標(biāo)準(zhǔn)品56-94-0250mg
SET易位蛋白/髓系相關(guān)蛋白抗體品牌298220-99-2 地錄雷他定雜質(zhì)標(biāo)準(zhǔn)品(NA) 10mg
孕同(P)Progesterone(P)3支/套，0.5ml/支
Lup-20(29)-ene-3β,23-diol 163060-07-9
Naraiptan Resolion Mixture那拉曲坦混合物標(biāo)準(zhǔn)品20mg那拉曲坦混合物標(biāo)準(zhǔn)品
常山乙素 24159-07-7 HPLC≥98%;20mg 訂購(gòu)|咨詢
|
|
|
|
|
